The Healthcare Data

KaliVir to Present at 2025 AACR Annual Meeting

KaliVir to Present at 2025 AACR Annual Meeting

KaliVir to Present at 2025 AACR Annual Meeting KaliVir Immunotherapeutics, Inc., a clinical-stage biotechnology company specializing in the development of advanced oncolytic immunotherapies, has announced its participation in the upcoming American Association for Cancer Research (AACR) Annual Meeting. The event,…